Compare · CLOV vs HUM
CLOV vs HUM
Side-by-side comparison of Clover Health Investments Corp. (CLOV) and Humana Inc. (HUM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CLOV and HUM operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $42.03B, about 20.8x CLOV ($2.02B).
- Over the past year, CLOV is up 31.3% and HUM is up 52.7% - HUM leads by 21.5 points.
- Both names hit the wire about 4 times in the past 4 weeks.
- HUM has more recent analyst coverage (25 ratings vs 12 for CLOV).
- Company
- Clover Health Investments Corp.
- Humana Inc.
- Price
- $3.92+2.48%
- $355.91+1.64%
- Market cap
- $2.02B
- $42.03B
- 1M return
- +39.43%
- +43.90%
- 1Y return
- +31.27%
- +52.72%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 4
- 4
- Recent ratings
- 12
- 25
Clover Health Investments Corp.
Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2014 and is headquartered in Franklin, Tennessee.
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest CLOV
- CEO, Counterpart Health Wai Conrad sold $879,500 worth of shares (220,426 units at $3.99) as part of a pre-agreed trading plan (SEC Form 4)
- Director Edwards Carladenise Armbrister sold $229,687 worth of shares (67,160 units at $3.42), decreasing direct ownership by 19% to 285,432 units (SEC Form 4)
- Interim CFO Thornton Joseph Clay covered exercise/tax liability with 16,942 shares, decreasing direct ownership by 1% to 1,217,584 units (SEC Form 4) (withholding obligation)
- Clover Health Investments Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 144 filed by Clover Health Investments Corp.
- CEO of Clover Care Services Priest Brady Patrick sold $345,097 worth of shares (98,039 units at $3.52), decreasing direct ownership by 5% to 2,040,222 units (SEC Form 4)
- Chief Executive Officer Toy Andrew covered exercise/tax liability with 85,704 shares, decreasing direct ownership by 0.86% to 9,923,301 units (SEC Form 4) (withholding obligation)
- SEC Form 10-Q filed by Clover Health Investments Corp.
- Clover Health Investments Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Clover Health Reports First Quarter 2026 Results
Latest HUM
- Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Humana completes $83 million Florida infrastructure investment to deepen coordinated patient care approach
- Humana upgraded by Deutsche Bank with a new price target
- Humana Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Humana, CenterWell and USAA Unite with VFW for National Day of Service Supporting Veterans Experiencing Homelessness
- Humana Invests More Than $1 Million to Advance Health Outcomes Across Louisiana
- Chief Financial Officer Mellet Celeste gave a grant of 15,387 units of Humana Common, decreasing direct ownership by 28% to 39,637 units (SEC Form 4)
- Chief Information Officer Mehta Japan was granted 9,448 units of Humana Common, increasing direct ownership by 122% to 17,176 units (SEC Form 4)
- President, Enterprise Growth Dintenfass David was granted 11,273 units of Humana Common, increasing direct ownership by 80% to 25,407 units (SEC Form 4)
- President & CEO Rechtin James A. was granted 35,633 units of Humana Common (SEC Form 4)